Medication info
Clopidogrel Tablets (Clopidogrel Hydrogen Sulfate)

Clopidogrel Tablets (Clopidogrel Hydrogen Sulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceuticals Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
For domestic use - 30 tablets per bottle, For domestic use - 100 tablets per bottle
Approval status
Active

MFDS item code 201310609 · Approved 2013.12.10 · Insurance code 622801740

Summary

Main use
Improvement of atherosclerosis; improvement of symptoms of acute coronary syndrome; prevention of thrombosis in atrial fibrillation
Who takes it
Adults
Adult dose
○ Adults 1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer 75 mg of clopidogrel orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start treatment on the first day with a loading dose of 300 mg of this medicine once daily, followed by a maintenance dose of 75 mg once daily orally. Aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. In patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment: Experience with treatment in patients with renal impairment is limited. ○ Patients with hepatic impairment: Experience with treatment in patients with moderate liver disease and a bleeding diathesis is limited. This medicine may be administered with or without food.

Ingredients

Manufacturer
Mothers Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of atherosclerosis; improvement of symptoms of acute coronary syndrome; prevention of thrombosis in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral arterial disease
  • acute coronary syndrome
  • unstable angina
  • non-Q-wave myocardial infarction
  • cardiovascular abnormalities
  • stroke
  • refractory ischemia
  • stroke
  • atherothrombotic incidents
  • thromboembolism
View approved original text

This medication helps improve atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction, or peripheral artery disease. It is also used to alleviate symptoms such as death due to cardiovascular abnormalities, myocardial infarction, stroke, or refractory ischemia in adult patients with acute coronary syndrome, such as unstable angina or non-Q-wave myocardial infarction who have received drug therapy, coronary intervention, or coronary artery bypass surgery. Additionally, it is prescribed to patients with atrial fibrillation who have one or more vascular risk factors, when anticoagulation with vitamin K antagonists is inappropriate and the risk of bleeding is low, to reduce the risk of thromboembolic complications such as stroke and thromboembolism. In summary, this medication is effectively used for various cardiovascular diseases and thrombus prevention.

How to take

Adult dose

○ Adults 1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer 75 mg of clopidogrel orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start treatment on the first day with a loading dose of 300 mg of this medicine once daily, followed by a maintenance dose of 75 mg once daily orally. Aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. In patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment: Experience with treatment in patients with renal impairment is limited. ○ Patients with hepatic impairment: Experience with treatment in patients with moderate liver disease and a bleeding diathesis is limited. This medicine may be administered with or without food.

Precautions

This medication helps prevent the aggregation of platelets in the blood to ensure proper circulation. It may be less effective for those who genetically have reduced functionality of a certain enzyme (CYP2C19), and alternative treatment options should be considered for such individuals. Additionally, co-administration of this medication with drugs that activate certain enzymes may increase the concentration of this medication and raise the risk of bleeding, so concurrent use with such medications is not recommended. Do not take this medication if you have an allergy to it or its components, have bleeding, have severe liver damage, are breastfeeding, or have certain hereditary lactose intolerance. Patients with a risk of bleeding or suspected bleeding symptoms should have an immediate blood test, and special caution should be exercised when combining with other antiplatelet or anticoagulant medications. Patients scheduled for surgery should discontinue this medication 5-7 days prior to the procedure and can restart after hemostasis has been achieved. Long-term use of this medication may result in side effects such as bleeding, reduction of blood cell counts, gastrointestinal disturbances, and skin rashes, so any unusual symptoms should be discussed with a doctor. Women who are pregnant or breastfeeding should consult with a specialist when taking this medication as it may affect the fetus or newborn, particularly in the case of delivery when there is a risk of bleeding, necessitating discontinuation. This medication is not recommended for use in children, as its safety and efficacy have not been established. Elderly patients or those with impaired kidney or liver function may have a higher risk of bleeding and require dosage adjustments and careful observation. Overdose of this medication can lead to prolonged bleeding time and severe hemorrhage, so immediate medical attention is necessary in case of overdose, as no specific antidote exists; treatments such as platelet transfusion may be required. This medication should be kept out of reach of children, and transferring it to another container is not advisable for quality maintenance.

Side effects

  • Hemorrhage
  • gastrointestinal bleeding
  • purpura
  • contusion
  • hematoma
  • epistaxis
  • hematoma
  • hematuria
  • intraocular hemorrhage
  • intracranial hemorrhage
Show 103 more
  • severe neutropenia
  • aplastic anemia
  • thrombocytopenia
  • gastrointestinal symptoms
  • abdominal pain
  • dyspepsia
  • diarrhea
  • nausea
  • rash
  • pruritus
  • chest pain
  • accidental injury
  • influenza-like illness
  • pain
  • fatigue
  • edema
  • hypertension
  • headache
  • dizziness
  • nausea
  • constipation
  • depression
  • dyspnea
  • rhinitis
  • bronchitis
  • cough
  • urinary tract infection
  • allergic symptoms
  • ischemic necrosis
  • generalized edema
  • gastritis
  • hemorrhagic gastroenteritis
  • duodenal ulcer
  • gastric ulcer
  • perforated gastric ulcer
  • upper gastrointestinal bleeding
  • bloating
  • hyperbilirubinemia
  • infectious hepatitis
  • fatty liver
  • hemorrhagic arthropathy
  • hematuria
  • hemoptysis
  • retroperitoneal hemorrhage
  • ocular hemorrhage
  • pulmonary hemorrhage
  • purpura
  • thrombocytopenia
  • anemia
  • aplastic anemia
  • hypochromic anemia
  • agranulocytosis
  • neutropenia
  • leukemia
  • leukopenia
  • neutropenia
  • eosinophilia
  • menorrhagia
  • hemothorax
  • herpes zoster
  • erythematous rash
  • maculopapular rash
  • urticaria
  • renal impairment
  • acute renal failure
  • gynecomastia
  • fever
  • loss of appetite
  • weight loss
  • visual disturbances
  • paresthesia
  • weight gain
  • facial flushing
  • reduced motor function
  • thirst
  • memory loss
  • cognitive disturbances
  • polyuria
  • arrhythmia
  • tremor
  • voice disorder
  • abnormal gait
  • hyperactivity
  • ataxia
  • hiccups
  • dysphagia
  • tongue disorders
  • abnormal behavior
  • rigidity
  • visual field defects
  • dry eyes
  • transient blindness
  • congestion
  • urinary disorders
  • uremia
  • hypoglycemia
  • bradycardia
  • tinnitus
  • contact dermatitis
  • elevated PSA
  • cholecystitis
  • hematemesis
  • spinal hematoma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering, ideally at room temperature between 1 and 30 degrees Celsius. Doing so helps maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

For domestic use - 30 tablets per bottle, For domestic use - 100 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.